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Abstract The effect of imperatoxin A (IpTxa) on the ryanodine
receptor type 3 (RyR3) was studied. IpTxa stimulates
[3H]ryanodine binding to RyR3-containing microsomes, but this
effect requires toxin concentrations higher than those required to
stimulate RyR1 channels. The effect of IpTxa on RyR3 channels
was observed at calcium concentrations in the range 0.1 WM to
10 mM. By contrast, RyR2 channels were not significantly
affected by IpTxa in the same calcium ranges. Single channel
current measurements indicated that IpTxa induced subconduc-
tance state in RyR3 channels that was similar to those observed
with RyR1 and RyR2 channels. These results indicate that IpTxa
is capable of inducing similar subconductance states in all three
RyR isoforms, while stimulation of [3H]ryanodine binding by this
toxin results in isoform-specific responses, with RyR1 being the
most sensitive channel, RyR3 displaying an intermediate
response and RyR2 the least responsive ones. ß 2001 Published
by Elsevier Science B.V. on behalf of the Federation of Euro-
pean Biochemical Societies.
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1. Introduction
Ryanodine receptors, RyRs, are intracellular Ca2 release
channels mainly known for their role in regulating Ca2 re-
lease from the sarcoplasmic reticulum of striated muscles [1].
Three di¡erent genes encoding distinct isoforms of RyRs are
known [2^5]. Recent evidence indicates that RyRs, in addition
to striated muscles, are co-expressed in several cell types and
that speci¢c combination of RyR isoforms may be important
to generate localized Ca2 release events [6^8] and to in£uence
cellular activities such as muscle contraction in neonatal skel-
etal muscle [9]. In neurons, co-expression of RyR isoforms
seems to be important to generate speci¢c changes in hippo-
campal synaptic plasticity and spatial learning [10]. However,
the mechanism(s) by which RyRs are activated in cells other
than muscle cells is not known.
Identi¢cation of the speci¢c regulatory properties of Ca2
release channels is important to better understand the molec-
ular basis of Ca2 signals. The Ca2 channel activity of the
three RyR isoforms is known to be sensitive to the e¡ects of
several physiological compounds among which Ca2 (at low
concentrations) and ATP promote the activity of the channels,
while Mg2 and Ca2 (at high concentrations) have an inhib-
itory e¡ect on channel activity [11]. Other compounds, such as
ca¡eine and ryanodine, although not physiological agonists of
these channels, have been used to study and di¡erentiate the
regulatory properties of the three isoforms. Cyclic adenosine
5P-diphosphate-ribose, a NAD derivative, is a strong candi-
date for a physiological activator of RyRs [12^16].
Imperatoxin A (IpTxa), a 33-amino acid peptide from the
venom of the African scorpion Pandinus imperator, has been
reported to stimulate [3H]ryanodine binding to RyR1 but not
to RyR2 channels [17^19]. Indeed, a structural domain of
IpTxa appears to share structural and functional homology
with an active peptide segment of the dihydropyridine recep-
tor (DHPR) K1S subunit. The peptide segment corresponds to
amino acids 666^690 of the II^III loop of the K1S subunit of
DHPR, which has been demonstrated to interact with RyR1
to trigger Ca2 release [20,21]. The peptide derived from the
II^III loop of the K1S can bind RyR1 and enhance
[3H]ryanodine binding. The homology between the II^III
loop of K1S and IpTxa peptides has also been substantiated
by competition experiments, where increasing concentrations
of the II^III loop peptide a¡ect the capacity of IpTxa to bind
RyR1 [19]. Here we report the response of RyR3 channels to
Ca2 and IpTxa. These results reveal an isoform selectivity of
this peptide in regulating RyR activity.
2. Materials and methods
2.1. Cell culture and transfection
About 8U105 HEK293 cells were plated on a 100 mm tissue culture
dish 24 h before transfection. One hour before DNA addition medium
was changed. 5 Wg of RyR3 expression vector and 5 Wg of carrier
DNA were mixed in a solution containing HBS (5 g/l HEPES, 8 g/l
NaCl, pH 7.1), 0.7 mM Na2HPO4, 0.7 mM NaH2PO4, 120 mM
CaCl2 and incubated for 30 min. Calcium phosphate precipitates
were added to cells and incubated for 6 h.
For stable transfections, cells were selected with Geneticin sulfate
G418 (Boehringer) at 800 Wg/ml.
2.2. Microsomal protein preparation
Bovine skeletal muscle and transfected cells were used to prepare
microsomal fractions containing RyR1 and RyR3 channels, respec-
tively. Microsomes were prepared as described previously [22,23].
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2.3. [3H]Ryanodine binding assay
[3H]Ryanodine (50^70 Ci/mmol) was from Amersham Life Science
(Amersham Place, UK). [3H]Ryanodine (7 nM) was incubated for 90
min at 36‡C with 30^50 Wg of microsomes from bovine skeletal muscle
or transfected cells in 0.1 ml of medium B containing 0.2 M KCl,
EGTA and CaCl2 necessary to set free Ca2 in the range from 10 nM
to 1 WM and 10 mM Na-HEPES (pH 7.2) in the absence or in the
presence of IpTxa. Saturation curve was obtained using di¡erent
[3H]ryanodine concentrations (0.5, 1, 3, 5, 10, 20 nM) in the same
previous medium.
Samples were always run in duplicate, ¢ltered through Whatman
GF/B glass ¢ber ¢lters, washed with 3U5 ml of medium B without
CaCl2 and 2U5 ml EtOH 10%. The ¢lters were placed in scintillation
vials, 5 ml of liquid scintillation added, and the radioactivity mea-
sured in a Tri-Carb 2100 TR Packard L-counter. The speci¢c binding
was de¢ned as the di¡erence between the binding in the absence (total
binding) and in the presence (non-speci¢c binding) of 20 WM unla-
beled ryanodine (Calbiochem, La Jolla, CA, USA).
2.4. Reconstitution of RyRs in planar lipid bilayers
Single channel recordings of RyRs were carried out as described
previously [19^21]. Channel fusion was facilitated by applying positive
voltage and the addition of Ca2 in the cis solution to a ¢nal con-
centration of 10 WM. Channel recordings were performed under sym-
metrical conditions of 200 mM Cs-methanesulfonate. The bilayer
membrane was held at constant potentials (usually 330 mV) when
recording channel activity and ‘rested’ at 0 mV during addition or
perfusion of IpTxa. Analysis of single channel data was performed
using the pClamp7 program and Origin 6.0 graphing software.
3. Results
3.1. Expression and characterization of RyR3 expressed in
HEK293 cells
To study the functional properties of RyR3, embryonic
human kidney cells (HEK293) were transfected with the
full-length RyR3 cDNA from mink lung epithelial cells
(Mv1Lu) [24,25] and di¡erent stable clones were isolated.
The levels of expression and the correct localization of the
recombinant RyR3 protein in the di¡erent selected clones
were tested by Western blot analysis and immuno£uorescence
experiments. For all experiments, a representative RyR3 ex-
pressing clone, 4-115, and non-transfected HEK293 cells were
used. Fig. 1A shows the Western blot analysis, performed
with a polyclonal antibody against RyR3, of 50 Wg of micro-
somes from bovine diaphragm (lane 1), RyR3-transfected cells
(lane 2), mock-transfected and non-transfected HEK293 cells
(lanes 3 and 4). The native and the recombinant RyR3 pro-
teins show a similar migration pro¢le, attesting that the RyR3
cDNA encodes a protein with molecular size and immunore-
activity indistinguishable from the native RyR3 channel. Im-
muno£uorescence staining of control and RyR3-transfected
HEK293 cells revealed that the RyR3 protein was localized
to the endoplasmic reticulum (Fig. 1C,D). In addition, dose-
dependent [3H]ryanodine binding to the microsomal fraction
of transfected cells was carried out. Fig. 1B reports the satu-
ration curve obtained by incubating 50 Wg of RyR3 micro-
somes with concentrations of [3H]ryanodine varying from 0.5
to 20 nM. RyR3 showed a dissociation constant (Kd) for
ryanodine of 9.2 nM and a maximal receptor density (Bmax)
of 0.262 pmol/mg protein.
It has been shown that Ca2 has a biphasic e¡ect on the
RyR channel activity depending on a di¡erent Ca2 concen-
tration that gives rise to a bell-shaped curve [11]. To inves-
tigate the Ca2 sensitivity of RyR3 channels, [3H]ryanodine
Fig. 1. Expression of RyR3 proteins. A: 50 Wg of microsomes prepared from bovine diaphragm (lane 1), RyR3-transfected cells (4-115 clone)
(lane 2), pcDNA3-transfected cells (lane 3) and untransfected HEK293 cells (lane 4) were tested for RyR3 protein by Western blot analysis.
B: 50 Wg of RyR3 microsomes (4-115 clone) were incubated for 90 min at 36‡C with 0.5^20 nM [3H]ryanodine in a solution containing 0.2 M
KCl, 10 mM HEPES pH 7.4, 10 WM Ca2. Non-speci¢c binding was de¢ned as the binding of [3H]ryanodine in the presence of 20 WM unla-
beled ryanodine and has been subtracted in this and subsequent ¢gures. The amount of [3H]ryanodine bound was measured by membrane ¢l-
tration on Whatman GF/B ¢lters. Inset, Scatchard plot of saturation data of the speci¢c binding. The Kd and Bmax values were 9.8 nM and
0.262 pmol/mg of protein, respectively. C,D: Expressed RyR3 proteins were detected by immuno£uorescence staining of untransfected (C) and
transfected HEK293 (D) cells using anti-RyR3 antibody.
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binding assays were performed in the presence of increasing
concentrations of free Ca2. Fig. 2 shows the Ca2-dependent
response of the RyR3 channel. Speci¢c binding started to
increase at 500 nM Ca2 (pCa 6.5) and was maximal at 100
WM Ca2 (pCa 4). At higher [Ca2], [3H]ryanodine binding
started to decrease. In addition to the Ca2 sensitivity curve
of RyR3 channels, Fig. 2 reports also similar experiments
performed with RyR1 channels. Under these conditions, no
major di¡erence could be detected in the activating kinetics of
the two channels. However, a small but signi¢cant di¡erence
between RyR1 and RyR3 was observed at concentrations be-
tween 1 and 10 mM Ca2, which corresponds to the inactivat-
ing part of the curve.
3.2. Dose^response e¡ect of IpTxa on RyR3
To test whether RyR3 channels were a¡ected by IpTxa,
[3H]ryanodine binding assays were carried out with recombi-
nant RyR3 protein expressed in HEK293 cells. Fig. 3A shows
the dose-dependent e¡ect of IpTxa at concentrations between
1 and 100 nM on [3H]ryanodine binding to RyR3 microsomes
in the presence of 10 WM Ca2. [3H]Ryanodine binding in the
absence of IpTxa was considered 100%. IpTxa was unable to
enhance the [3H]ryanodine binding to RyR3 microsomes at
concentrations of 1 and 5 nM. At 10 and 100 nM IpTxa the
[3H]ryanodine binding reached a value of 109.0 þ 8.1% and
155.8 þ 12.8%, respectively. In contrast, IpTxa stimulated
[3H]ryanodine binding to RyR1 at a concentration of 5 nM
(118.3 þ 10.0%) and stimulation increased to 150.6 þ 4.7% and
to 241.2 þ 5.9% in the presence of 10 and 100 nM IpTxa,
respectively (Fig. 3B).
3.3. Di¡erential sensitivity of RyR isoforms to IpTxa :
enhancement of [3H]ryanodine binding
IpTxa has been found to preferentially stimulate
[3H]ryanodine binding to RyR1 and not to RyR2 channels
[18,19]. The e¡ect of IpTxa on RyR3 was therefore compared
with those obtained on RyR1 and RyR2 channels (Fig. 4). In
agreement with previous experiments, in the presence of 100
nM IpTxa, the binding of [3H]ryanodine to RyR3 microsomes
was increased up to 151.0 þ 6.7%. The same IpTxa concentra-
tion stimulated [3H]ryanodine binding to RyR1 to
219 þ 36.1%. No activation of [3H]ryanodine binding was ob-
served when RyR2 channels were used. These results con-
¢rmed that IpTxa can increase [3H]ryanodine binding to
RyR3 channels. This e¡ect, although less pronounced than
that obtained to RyR1, was signi¢cantly higher than that
observed with RyR2 channels.
3.4. Ca2+ dependence of IpTxa e¡ects on RyR3 channel
IpTxa has been reported to activate [3H]ryanodine binding
to RyR1 channels over a wide range of Ca2 concentrations,
producing a generalized increment of the bell-shaped binding
curve. However, IpTxa displays erroneous e¡ects on RyR2,
activating binding moderately at low [Ca2] and inhibiting it
also moderately at high [Ca2] [18,26]. This e¡ect by IpTxa
transforms the bell-shaped [3H]ryanodine binding curve of
RyR2 into a sigmoidal curve [18,26], suggesting that Ca2
activation and inhibition sites are not a¡ected equally by
the peptide. Therefore, we analyzed the e¡ect of IpTxa on
the Ca2 dependence of [3H]ryanodine binding to RyR3 chan-
Fig. 2. Ca2 dependence of [3H]ryanodine binding. 50 Wg of micro-
somes from bovine muscle, expressing RyR1, 50 Wg of microsomes
from RyR3-transfected cells were incubated with 7 nM [3H]-
ryanodine in a solution containing 0.2 M KCl, 10 mM HEPES pH
7.2, for 1.5 h at 36‡C with various concentrations of free Ca2 bu¡-
ered with EGTA. Binding was normalized on the maximum binding
value at 100 WM Ca2. Data are the mean þ S.D. of n = 18 (RyR1)
and n = 18 (RyR3).
Fig. 3. E¡ect of IpTxa on [3H]ryanodine binding. A: [3H]Ryanodine
(7 nM) was incubated with 50 Wg of RyR3 microsomes in 0.2 M
KCl, 10 WM CaCl2 and 10 mM Na-HEPES (pH 7.2) for 90 min at
36‡C in the presence of 1, 5, 10, 100 nM IpTxa. Control binding
(100%) was de¢ned as the speci¢c binding of [3H]ryanodine in the
absence of peptide toxin. Data are the mean ( þ S.E.M. of n = 5, 2,
7, 6 for 1, 5, 10 and 100 nM IpTxa) of the percentage of binding
increment induced by IpTxa. B: [3H]Ryanodine binding to RyR1
microsomes was carried out under the same conditions. Data are
the mean þ S.E.M. of n = 9, 3, 10, 9 for 1, 5, 10 and 100 nM IpTxa,
respectively.
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nels. Again, RyR1 was a pivotal comparison, both as a pos-
itive control for IpTxa and as an index of binding a⁄nities of
the Ca2 activation and inhibition sites.
Fig. 5A shows that in the presence of IpTxa (¢lled circles),
the binding curve maintains a bell shape and is increased
about 1.5-fold compared to control. Moreover, IpTxa acti-
vates [3H]ryanodine binding at all [Ca2], except for pCa 7
and pCa 2. The Ca2 dependence of [3H]ryanodine binding to
RyR1 is shown in Fig. 5B. In the absence of IpTxa (control,
open circles) [3H]ryanodine binding reached the maximum
value at pCa 4, falling sharply at pCa 3. In the presence of
IpTxa (¢lled circles) [3H]ryanodine binding increased up to
835.0 þ 6.9 fmol/mg protein at pCa 4, or about four-fold com-
pared to control. At pCa 6, in the presence of IpTxa, the
[3H]ryanodine binding to RyR3 was still increasing although
the [3H]ryanodine binding to RyR1 reached almost the pla-
teau.
3.5. Single channel analysis of IpTxa e¡ects on RyR3 channels
In a previous report, Tripathy et al. showed that RyR2,
although insensitive to IpTxa in [3H]ryanodine binding assays,
was modi¢ed by the peptide in lipid bilayer recordings. A
side-by-side comparison of e¡ects of IpTxa on RyR1 and
RyR2 revealed that the peptide increased [3H]ryanodine bind-
ing to RyR1 only, even though IpTxa induced the appearance
of kinetically indistinguishable subconductance states on
RyR1 and RyR2 [26]. Thus, IpTxa presents itself as a modu-
lator of RyRs with the rare property of producing divergent
e¡ects on [3H]ryanodine binding and lipid bilayer assays. To
test whether IpTxa was capable of modifying the single chan-
nel behavior of RyR3, we reconstituted microsomes from
HEK293 cells expressing RyR3 and skeletal muscle micro-
somes (as source of RyR1) into lipid bilayers and recorded
single channel activity in the absence and the presence of
IpTxa. As in previous studies [19,26], we recognized RyRs
by their characteristic fast-£ickering, high-conductance
(V700 pS in monovalent cations) openings, their Ca2 depen-
dence, and their response to ryanodine (not shown).
Fig. 6 shows that IpTxa modi¢ed the activity of both RyR1
and RyR3 in a similar manner. Less than 1 min after addition
of 300 nM IpTxa to the cis (cytosolic) side of the channel,
RyR1 and RyR3 openings were transformed into long-lived
subconductance states of V30% amplitude relative to the full
conductance. Although of small amplitude, the IpTxa-induced
subconductance state displayed a mean open time that was
s 100-fold longer than that of unmodi¢ed channels. Ion £ow
would therefore be expected to be greater for an IpTxa-modi-
¢ed channel, despite its lower conductance. Thus, in the case
of RyR1 and RyR3, the e¡ects of IpTxa at the single channel
level appear to be convergent with its e¡ects on [3H]ryanodine
binding assays.
4. Discussion
A large number of physiological and pharmacological mod-
ulators of RyR channel activity have been tested to distin-
guish their capacity to di¡erentiate the modality of activation
and inactivation of the channels encoded by three RyR iso-
forms [11]. However, while a large number of data on regu-
lation of RyR1 and RyR2 channels have been reported, far
less is known about RyR3 channels. Most of the work per-
formed on RyR3 channels has so far explored the sensitivity
of these channels to Ca2. Although it is commonly accepted
that Ca2 has a biphasic e¡ect on RyRs (activating at low and
inhibitory at high concentrations), controversial results have
been reported when comparing the activation and inactivation
kinetics of RyR3 channels using di¡erent techniques. Single
channel recordings of RyR3 channels reconstituted in lipid
bilayer have revealed a 10-fold lower sensitivity to inactiva-
Fig. 4. E¡ect of IpTxa on [3H]ryanodine binding to RyRs. 50 Wg of
RyR1 microsomes from bovine muscle, of RyR2 microsomes from
bovine heart and microsomes from RyR3-transfected cells were in-
cubated with 7 nM [3H]ryanodine in 0.2 M KCl, 10 mM HEPES
pH 7.4, 10 WM Ca2 for 90 min at 36‡C in the presence of 100 nM
IpTxa. The binding of [3H]ryanodine in the absence of IpTxa corre-
sponds to the control (100% speci¢c binding). Data are the mean þ
S.E.M. of n = 27 (RyR1), n = 5 (RyR2), and n = 15 (RyR3).
Fig. 5. Ca2 dependence of IpTxa activation of [3H]ryanodine bind-
ing. 50 Wg of recombinant RyR3 (A) and 30 Wg of bovine skeletal
(B) microsomes were incubated for 90 min at 36‡C with 7 nM
[3H]ryanodine in the absence (open squares) or in the presence
(¢lled squares) of 100 nM IpTxa. The incubation medium consisted
of 0.2 M KCl, 10 mM Na-HEPES (pH 7.4) and CaCl2 and EGTA
concentrations to yield the indicated free [Ca2]. Ca2 :EGTA ratios
were calculated using the stability constants given by Fabiato [3].
Data points are the mean ( þ S.E.M.) of two independent determina-
tions.
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tion by high Ca2 concentrations for RyR3 compared to
RyR1 channels [15,16,27^29]. In contrast to single channel
data, Murayama and Ogawa [30^31] reported that, in
[3H]ryanodine binding assays, a small but signi¢cant di¡er-
ence was observed only at low (activating) Ca2 concentra-
tions, while inactivation at higher Ca2 concentrations was
comparable between RyR1 and RyR3 channels. In the
[3H]ryanodine binding experiments described in the present
report, a somewhat lower sensitivity to Ca2 inactivation for
RyR3 channels was observed compared to RyR1 channels,
but this is certainly less evident than that reported in single
channel analysis [15,16,27^29]. Whether these discrepancies
re£ect the regulatory e¡ects of accessory proteins that are
present in microsomal preparations used for [3H]ryanodine
binding and that are lost under experimental conditions for
single channel analysis in lipid bilayers, similarly to what is
reported for Calmodulin and InsP3 receptors [32], is currently
unknown.
A clearer distinction between the properties of the RyR3
channels and those of the two other RyR isoforms has been
obtained by studying the e¡ects of IpTxa on [3H]ryanodine
binding. In this study, we found that IpTxa stimulates
[3H]ryanodine binding to RyR3 channels. Although this re-
sponse was smaller than that observed with RyR1 channels,
which where activated at lower concentrations of IpTxa, and
reached higher levels of activation at saturating concentra-
tions of IpTxa, the e¡ects of IpTxa on RyR3 channels di¡ered
from those observed with RyR2 channels. For example, the
latter were found to be essentially insensitive to IpTxa, in
agreement with previous reports [18,19]. Similar to e¡ects
with RyR1 and again at variance with those on RyR2 chan-
nels [18,26], the e¡ect of IpTxa on RyR3 channels was ob-
served at all Ca2 concentrations. Enhancement of
[3H]ryanodine binding was in fact observed both at Ca2 con-
centrations that usually increase ryanodine binding to RyR3
channels as well as at Ca2 concentrations that inhibit the
binding.
An intriguing aspect, emerging from this and from previous
studies on IpTxa e¡ects on RyRs, is the apparent discrepancy
between the distinctive responses in [3H]ryanodine binding of
the three RyR isoforms and the fact that, in single channel
experiments, all three isoforms display a similar subconduc-
tance state following IpTxa treatment [19,26]. In this respect,
it is interesting to note that IpTxa shares some resemblance
with a region of the K1 subunit of the skeletal muscle (K1S)
DHPR that has been implicated in binding to and activation
of RyR1 channels [19]. However, in contrast to the e¡ect on
RyR1, the II^III loop of K1S can neither bind nor activate
RyR2 channels [20]. Actually, indirect evidence suggests that
RyR3, like RyR2 channels, is not directly activated by the K1S
DHPR in skeletal muscle [33,34]. Therefore, the question is
how can IpTxa (1) have distinctive e¡ects on RyR isoforms as
measured by [3H]ryanodine binding (which is usually known
to directly correlate with the open state of the channel); (2) be
able to induce an almost identical subconductance in all three
channels and (3) share an intriguing homology with the K1S
subunit that can activate and bind only RyR1 channels?
One way to rationalize these data is to divide the e¡ects of
IpTxa binding to RyRs in two events. The ¢rst event is an
event common to all isoforms, which results in the induction
of the subconductance state observed in single channel anal-
ysis in all three isoforms. Tripathy et al. [26] raised the ques-
tion whether the subconductance state induced by IpTxa is
due to occlusion by the toxin of the vestibule of the channels
Fig. 6. E¡ect of IpTxa on single channel recording of RyRs. IpTxa induces a subconductance state in RyR1 and RyR3 channels. The top re-
cordings were obtained under control conditions and the bottom recordings after addition of 300 nM IpTxa to the cis solution.
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or due to a conformational change. While this question is not
de¢nitively answered, the conformational change hypothesis is
more favored. Here we propose that, in addition to this ¢rst
event, which results in an equivalent change in all three iso-
forms, IpTxa can also induce an additional isoform-speci¢c
conformational change. This isoform-speci¢c conformational
change would then be responsible for the di¡erences observed
in [3H]ryanodine binding experiments in the presence of IpTxa
with the three RyR isoforms. Whether DHPR and IpTxa bind
to the same site or to di¡erent sites on RyR1 channels is not
known. Recent results indicate that there could be multiple
sites of interaction between K1S DHPR and RyR1 and that
more than one region in both molecules are involved in RyR1/
DHPR interaction [35,36]. It is therefore likely that IpTxa
either binds to a smaller region of a larger interacting domain
or to a site distinct from that of the K1S DHPR. In both cases
the determinant of IpTxa binding has to be conserved among
the three isoforms, while those sequences that are necessary
for K1S DHPR binding in RyR1 are obviously not conserved
in RyR2 and RyR3.
Recently images of IpTxa bound to RyR1 have been ob-
tained by cryo-electronmicroscopy (EM) and three-dimension-
al reconstruction techniques [37]. Should the structure of the
IpTxa-bound RyR1 channels be distinguishable from those of
IpTxa-bound RyR2 and RyR3 channels, the hypothesized dif-
ferences in conformation induced in RyR isoforms by IpTxa
could be experimentally tested in the future by cryo-EM tech-
niques.
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